Tuberculosis Research Today is a free monthly online journal that collates and summarizes the latest research about Tuberculosis, including details on symptoms, causes, treatment, pulmonary, mycobacterium.

Volume 2 (2005), Issue 2 (February)

1. How many sputum specimens are necessary to diagnose pulmonary tuberculosis?
   Am J Infect Control, 33(1): 58-61. [Abstract] [Full-text]
2. Tuberculosis among health care workers in a short working period.
   Am J Infect Control, 33(1): 23-6. [Abstract] [Full-text]
3. Drug resistance in tuberculosis.
   Eur Respir J, 25(2): 376-9. [Abstract] [Full-text]
4. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
   Int Immunopharmacol, 5(3): 591-9. [Abstract] [Full-text]
5. Immunological characterization of novel secreted antigens of Mycobacterium tuberculosis.
   Scand J Immunol, 61(2): 139-46. [Abstract] [Full-text]
6. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
   Tuberculosis (Edinb), 85(1): 115-26. [Abstract] [Full-text]
7. Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice.
   Tuberculosis (Edinb), 85(1): 107-14. [Abstract] [Full-text]
8. Cell-mediated immune responses in children towards secreted proteins of Mycobacterium bovis BCG.
   Tuberculosis (Edinb), 85(1): 89-93. [Abstract] [Full-text]
9. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
   Tuberculosis (Edinb), 85(1): 73-9. [Abstract] [Full-text]
10. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.
    Tuberculosis (Edinb), 85(1): 65-72. [Abstract] [Full-text]
11. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
    Tuberculosis (Edinb), 85(1): 47-52. [Abstract] [Full-text]
12. Advancing TB vaccines to Phase I clinical trials in the US: regulatory/manufacturing/licensing issues.
    Tuberculosis (Edinb), 85(1): 39-46. [Abstract] [Full-text]
13. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
    Tuberculosis (Edinb), 85(1): 29-38. [Abstract] [Full-text]
14. NIH pre-clinical screening program: overview and current status.
    Tuberculosis (Edinb), 85(1): 25-8. [Abstract] [Full-text]
15. Cattle as a model for development of vaccines against human tuberculosis.
    Tuberculosis (Edinb), 85(1): 19-24. [Abstract] [Full-text]
16. Mouse and guinea pig models for testing new tuberculosis vaccines.
    Tuberculosis (Edinb), 85(1): 13-7. [Abstract] [Full-text]
17. The tuberculosis vaccine challenge.
    Tuberculosis (Edinb), 85(1): 7-12. [Abstract] [Full-text]
18. TB vaccines for the World.
    Tuberculosis (Edinb), 85(1): 1-6. [Abstract] [Full-text]
19. Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from south India.
    Soc Sci Med, 60(8): 1845-53. [Abstract] [Full-text]
20. How soon does cutaneous tuberculosis respond to treatment? Implications for a therapeutic test of diagnosis.
    Int J Dermatol, 44(2): 121-4. [Abstract] [Full-text]
21. Expansile pneumonia in children caused by Mycobacterium tuberculosis: clinical, radiological, and bronchoscopic appearances.
    Pediatr Pulmonol, 38(6): 451-5. [Abstract] [Full-text]
22. Tenosynovitis of the wrist due to resistant Mycobacterium tuberculosis in a heart transplant patient.
    J Clin Microbiol, 43(2): 988-90. [Abstract] [Full-text]
23. Lot quality assurance sampling of sputum acid-fast bacillus smears for assessing sputum smear microscopy centers.
    J Clin Microbiol, 43(2): 913-5. [Abstract] [Full-text]
24. Long-term molecular analysis of tuberculosis strains in alabama, a state characterized by a largely indigenous, low-risk population.
    J Clin Microbiol, 43(2): 870-8. [Abstract] [Full-text]
25. Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the United States.
    J Clin Microbiol, 43(2): 688-95. [Abstract] [Full-text]
26. Peripancreatic tuberculosis mimicking pancreatic neoplasia.
    J Gastrointest Surg, 9(2): 254-62. [Abstract] [Full-text]
27. Thinking the unthinkable: Alzheimer's, Creutzfeldt-Jakob and Mad Cow disease: the age-related reemergence of virulent, foodborne, bovine tuberculosis or losing your mind for the sake of a shake or burger.
    Med Hypotheses, 64(4): 699-705. [Abstract] [Full-text]
28. Relationship between intracranial granulomas and cerebrospinal fluid levels of gamma interferon and interleukin-10 in patients with tuberculous meningitis.
    Clin Diagn Lab Immunol, 12(2): 363-5. [Abstract] [Full-text]
29. Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis.
    Clin Diagn Lab Immunol, 12(2): 354-8. [Abstract] [Full-text]
30. Mycobacteria other than Mycobacterium tuberculosis are not present in erythema induratum/nodular vasculitis: a case series and literature review of the clinical and histologic findings.
    J Cutan Pathol, 32(3): 220-6. [Abstract] [Full-text]
31. Isolated medial cuneiform tuberculosis: a case report.
    J Foot Ankle Surg, 44(1): 60-3. [Abstract] [Full-text]
32. Lupus vulgaris--report of a case with facial involvement.
    Br Dent J, 198(3): 135-7. [Abstract] [Full-text]
33. A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis.
    Chest, 127(2): 643-51. [Abstract] [Full-text]
34. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection.
    Vaccine, 23(14): 1680-5. [Abstract] [Full-text]
35. Paratuberculosis and avian tuberculosis infections in one red deer farm studied by IS900 and IS901 RFLP analysis.
    Vet Microbiol, 105(3): 261-8. [Abstract] [Full-text]
36. Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy.
    Clin Biochem, 38(3): 234-8. [Abstract] [Full-text]
37. Cytokine responses induced by Mycobacterium tuberculosis in patients with HIV-1 infection and tuberculosis.
    Int J Infect Dis, 9(2): 110-6. [Abstract] [Full-text]
38. Epstein-Barr virus associated with primary CNS lymphoma and disseminated BCG infection in a child with AIDS.
    Int J Infect Dis, 9(2): 96-103. [Abstract] [Full-text]
39. Gamma delta T cell responses associated with the development of tuberculosis in health care workers.
    FEMS Immunol Med Microbiol, 43(3): 339-50. [Abstract] [Full-text]
40. Jails, a neglected opportunity for tuberculosis prevention.
    Am J Prev Med, 28(2): 225-8. [Abstract] [Full-text]
41. Tuberculosis transmission in nontraditional settings: a decision-tree approach.
    Am J Prev Med, 28(2): 201-7. [Abstract] [Full-text]
42. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.
    J Infect Dis, 191(6): 856-65. [Abstract] [Full-text]
43. Variable outcome of experimental interferon-gamma therapy of disseminated Bacillus Calmette-Guerin infection in two unrelated interleukin-12Rbeta1-deficient Slovakian children.
    Eur J Pediatr, 164(3): 166-72. [Abstract] [Full-text]
44. Clinic staff perceptions of tuberculosis treatment delivery in Bali.
    Patient Educ Couns, 56(3): 340-8. [Abstract] [Full-text]
45. Mechanisms of mycobacterial persistence in tuberculosis.
    Clin Immunol, 114(3): 239-47. [Abstract] [Full-text]
46. Tuberculous meningitis: many questions, too few answers.
    Lancet Neurol, 4(3): 160-70. [Abstract] [Full-text]
47. Expression and purification of recombinant 38-kDa and Mtb81 antigens of Mycobacterium tuberculosis for application in serodiagnosis.
    Protein Expr Purif, 40(1): 169-76. [Abstract] [Full-text]
48. Elbow tuberculosis: an unusual location and diagnostic problem.
    Arch Orthop Trauma Surg, 125(1): 56-8. [Abstract] [Full-text]
49. Pulmonary tuberculosis and extreme prematurity.
    Arch Dis Child Fetal Neonatal Ed, 90(2): F178-9; discussion F179-83. [Abstract] [Full-text]
50. Mycobacterium tuberculosis infection and FHIT gene alterations in lung cancer.
    Cancer Lett, 219(2): 155-62. [Abstract] [Full-text]
51. A case of tuberculosis verrucosa cutis--undiagnosed for 44 years and resulting in fixed-flexion deformity of the arm.
    Clin Exp Dermatol, 30(2): 149-51. [Abstract] [Full-text]
52. Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination.
    J Infect Chemother, 11(1): 18-23. [Abstract] [Full-text]
53. Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.
    Antimicrob Agents Chemother, 49(3): 1229-31. [Abstract] [Full-text]
54. Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Antimicrob Agents Chemother, 49(3): 1209-12. [Abstract] [Full-text]
55. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule.
    J Exp Med, 201(4): 535-43. [Abstract] [Full-text]
56. Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
    BMC Public Health, 5: 14. [Abstract] [Full-text]
57. Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis.
    Infect Immun, 73(3): 1903-5. [Abstract] [Full-text]
58. Mycobacterium tuberculosis with disruption in genes encoding the phosphate binding proteins PstS1 and PstS2 is deficient in phosphate uptake and demonstrates reduced in vivo virulence.
    Infect Immun, 73(3): 1898-902. [Abstract] [Full-text]
59. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice.
    Infect Immun, 73(3): 1744-53. [Abstract] [Full-text]
60. Collaboration between private pharmacies and national tuberculosis programme: an intervention in Bolivia.
    Trop Med Int Health, 10(3): 246-50. [Abstract] [Full-text]
61. Clinical investigation: increased serum stromal derived factor 1 alpha levels in pulmonary tuberculosis.
    Clin Exp Immunol, 139(3): 490-7. [Abstract] [Full-text]
62. Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice.
    Clin Exp Immunol, 139(3): 398-404. [Abstract] [Full-text]
63. Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in human archaeological samples: a possible explanation for the historical decline of leprosy.
    Proc Biol Sci, 272(1561): 389-94. [Abstract] [Full-text]
64. Improving tuberculosis therapy completion after jail: translation of research to practice.
    Health Educ Res, 20(2): 163-74. [Abstract] [Full-text]

© 2004-2008 Tuberculosis Research Today. All Rights Reserved.